Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax - Top-Institutions - MDSpire

Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax

  • By

  • Fangli Chen

  • Yuanqin Wang

  • Zhen Fu

  • Li Chang

  • Xuewei Jiang

  • Zhizhi Zhang

  • Chongyang Li

  • Ligen Liu

  • Li Yang

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology
  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology
  • #3

    Duke University School of Medicine
    Duke University School of Medicine

    Durham, North Carolina

    Key Differentiators

    • Hematology
    • Oncology
  • #4

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Hematology
    • Oncology
  • #5

    Royal Melbourne Hospital
    Royal Melbourne Hospital

    Melbourne, Victoria

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Related Content